NO160136C - Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av benzoylfenylpiperidin. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av benzoylfenylpiperidin.

Info

Publication number
NO160136C
NO160136C NO822185A NO822185A NO160136C NO 160136 C NO160136 C NO 160136C NO 822185 A NO822185 A NO 822185A NO 822185 A NO822185 A NO 822185A NO 160136 C NO160136 C NO 160136C
Authority
NO
Norway
Prior art keywords
benzoylphenylpiperidine
preparation
active derivatives
therapeutic active
analogue procedure
Prior art date
Application number
NO822185A
Other languages
English (en)
Norwegian (no)
Other versions
NO160136B (no
NO822185L (no
Inventor
Bernard Majoie
Francois Bellamy
Pierre Dodey
Jacques Robin
Original Assignee
Fournier Innovation Synergie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fournier Innovation Synergie filed Critical Fournier Innovation Synergie
Publication of NO822185L publication Critical patent/NO822185L/no
Publication of NO160136B publication Critical patent/NO160136B/no
Publication of NO160136C publication Critical patent/NO160136C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO822185A 1981-06-29 1982-06-28 Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av benzoylfenylpiperidin. NO160136C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8112745A FR2508445A1 (fr) 1981-06-29 1981-06-29 Nouveaux derives de benzoyl-phenyl-piperidine, leur procede de preparation et leur application, notamment en therapeutique

Publications (3)

Publication Number Publication Date
NO822185L NO822185L (no) 1982-12-30
NO160136B NO160136B (no) 1988-12-05
NO160136C true NO160136C (no) 1989-03-15

Family

ID=9259970

Family Applications (1)

Application Number Title Priority Date Filing Date
NO822185A NO160136C (no) 1981-06-29 1982-06-28 Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av benzoylfenylpiperidin.

Country Status (26)

Country Link
US (2) US4528294A (xx)
EP (1) EP0069012B1 (xx)
JP (1) JPS588061A (xx)
KR (1) KR880001298B1 (xx)
AR (1) AR230048A1 (xx)
AT (1) ATE9795T1 (xx)
AU (1) AU550320B2 (xx)
CA (1) CA1187501A (xx)
CS (1) CS235542B2 (xx)
DD (1) DD202557A5 (xx)
DE (1) DE3260949D1 (xx)
DK (1) DK152668C (xx)
ES (1) ES513565A0 (xx)
FI (1) FI77447C (xx)
FR (1) FR2508445A1 (xx)
GR (1) GR76401B (xx)
HU (1) HU189150B (xx)
IE (1) IE53189B1 (xx)
IL (2) IL66123A (xx)
NO (1) NO160136C (xx)
OA (1) OA07133A (xx)
PH (1) PH17368A (xx)
PT (1) PT75135B (xx)
SU (1) SU1147251A3 (xx)
YU (1) YU43799B (xx)
ZA (1) ZA824536B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL82573A0 (en) * 1986-05-30 1987-11-30 Sori Soc Rech Ind Preparation of benzoylphenyl-piperidine derivatives
FR2620027A1 (fr) * 1987-09-09 1989-03-10 Fournier Innovation Synergie Nouvelle utilisation de la (5-amino-2-(4-methyl-1-piperidinyl)phenyl)-(4-chlorophenyl)-methanone
AU4971600A (en) * 1999-05-21 2000-12-12 Eli Lilly And Company Immunopotentiator agents
EP1286984A2 (en) * 2000-03-10 2003-03-05 Pharmacia Corporation Method for the preparation of tetrahydrobenzothiepines

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3202655A (en) * 1962-04-27 1965-08-24 Yvon G Perron 6-[alpha-substituted-alpha-(2-or 3-heterocyclic) acetamido] penicillanic acid and nontoxic salts thereof
NL124621C (xx) * 1962-11-13
FR1375300A (fr) * 1962-11-13 1964-10-16 Hoffmann La Roche Dérivés de benzophénone et leur préparation
FR1403939A (fr) * 1963-06-07 1965-06-25 Hoffmann La Roche Procédé pour la préparation de dérivés de benzodiazépine
FR1526708A (fr) * 1966-06-13 1968-05-24 Upjohn Co 1.3-amino-alcools, leurs intermédiaires et dérivés et leur procédé de préparation
US3668199A (en) * 1966-06-13 1972-06-06 Upjohn Co 1,3-aminoalcohols
FR1530393A (fr) * 1966-07-11 1968-06-21 Hoffmann La Roche Procédé pour la préparation de dérivés de pipéridine
IE34545B1 (en) * 1969-10-01 1975-06-11 Continental Pharma Amino-alcohols,their salts and process for preparing the same
HU167950B (xx) * 1973-07-26 1976-01-28
US4064121A (en) * 1973-07-26 1977-12-20 Richter Gedeon Vegyeszeti Gyar Rt. Substituted nitrobenzophenone derivatives and a process for the preparation thereof
HU167949B (xx) * 1973-07-26 1976-01-28
US4021563A (en) * 1975-02-06 1977-05-03 Sven Eric Harry Hernestam Method of treating cardiac arrhythmia with γ-piperidino-butyrophenones
IE49998B1 (en) * 1979-08-06 1986-01-22 Merrell Dow Pharma 4-(naphthalenyloxy)piperidine derivatives

Also Published As

Publication number Publication date
FI822215L (fi) 1982-12-30
EP0069012B1 (fr) 1984-10-10
PT75135B (fr) 1984-05-25
EP0069012A1 (fr) 1983-01-05
CS235542B2 (en) 1985-05-15
YU43799B (en) 1989-12-31
PH17368A (en) 1984-08-06
JPH0127062B2 (xx) 1989-05-26
FI77447C (fi) 1989-03-10
ES8304936A1 (es) 1983-03-16
IE821475L (en) 1982-12-29
JPS588061A (ja) 1983-01-18
DD202557A5 (de) 1983-09-21
KR880001298B1 (ko) 1988-07-22
AU8542982A (en) 1983-01-06
ZA824536B (en) 1983-04-27
IL66123A0 (en) 1982-09-30
OA07133A (fr) 1984-03-31
GR76401B (xx) 1984-08-10
DK152668C (da) 1988-09-19
DK152668B (da) 1988-04-11
US4680402A (en) 1987-07-14
NO160136B (no) 1988-12-05
US4528294A (en) 1985-07-09
IL76287A0 (en) 1986-01-31
KR840000514A (ko) 1984-02-22
ATE9795T1 (de) 1984-10-15
AU550320B2 (en) 1986-03-20
IL66123A (en) 1986-02-28
FI822215A0 (fi) 1982-06-21
SU1147251A3 (ru) 1985-03-23
FR2508445A1 (fr) 1982-12-31
DK289382A (da) 1982-12-30
HU189150B (en) 1986-06-30
PT75135A (fr) 1982-07-01
DE3260949D1 (en) 1984-11-15
ES513565A0 (es) 1983-03-16
IE53189B1 (en) 1988-08-17
YU141582A (en) 1985-03-20
FR2508445B1 (xx) 1984-02-10
AR230048A1 (es) 1984-02-29
NO822185L (no) 1982-12-30
CA1187501A (en) 1985-05-21
FI77447B (fi) 1988-11-30

Similar Documents

Publication Publication Date Title
NO156785C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater.
NO164025C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater.
NO155774C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo-diazepin-derivater.
NO159016C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminderivater.
NO162022C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive cefemderivater.
NO150760C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotiazoler.
NO161497C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.
NO821085L (no) Fremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater
NO874153D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater.
NO157296C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(4-indolyl-piperidino-alkyl)-benzimidazolon-derivater.
NO158876C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive adenosin-derivater.
NO154492C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme forbindelser.
NO164541C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater.
NO158460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO155771C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminopropanolderivater.
NO161066C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive kinolinderivater.
NO160079C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater.
NO158739C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater.
NO159090C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.
NO158800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater.
NO156167C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater.
NO163570C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acylaminomitosaner.
NO162188C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.
NO821882L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo-pyrido-diazepin-derivater
NO163617C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolidinon-derivater.